Sb-258741

Sb-258741

SCHEMBL4459020

Cc1cccc(S(=O)(=O)N2CCCC2CCN2CCC(C)CC2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR7 P34969 18/20 1.00
▸ HTR1B P28222 6/20 1.00
▸ DRD3 P35462 6/20 1.00
▸ HTR1A P08908 5/20 1.00
▸ DRD2 P14416 5/20 1.00
▸ HTR1D P28221 5/20 1.00
▸ HTR6 P50406 2/20 0.78
▸ CYP2D6 P10635 2/20 0.78
▸ HTR5A P47898 2/20 0.78
▸ HTR2B P41595 2/20 0.78
▸ CYP3A4 P08684 1/20 0.78
▸ CYP1A2 P05177 1/20 0.78
▸ HTR4 Q13639 1/20 0.78
▸ TMEM97 Q5BJF2 2/20 0.77
▸ ADRA2A P08913 1/20 0.77
▸ ADRA2B P18089 1/20 0.77
▸ ADRA2C P18825 1/20 0.77
▸ OPRM1 P35372 1/20 0.77
▸ OPRK1 P41145 1/20 0.77
▸ BLM P54132 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sb-258741 SCHEMBL4454954 1.00 HTR7 (1.00) HTR7HTR1BDRD3HTR1ADRD2
SCHEMBL375475 0.88 HTR7 (1.00) HTR7HTR1BDRD3HTR1ADRD2
SCHEMBL4298542 0.88 HTR7 (1.00) HTR7HTR1BDRD3HTR1ADRD2
SCHEMBL4298546 0.88 HTR7 (1.00) HTR7HTR1BDRD3HTR1ADRD2
SCHEMBL375474 0.88 HTR7 (1.00) HTR7HTR1BDRD3HTR1ADRD2
SCHEMBL5809435 0.88 HTR7 (0.78) HTR7HTR1BDRD3HTR1ADRD2
SCHEMBL17195119 0.87 HTR7 (0.77) HTR7HTR1BDRD3HTR1ADRD2
SCHEMBL14117920 0.87 HTR7 (0.77) HTR7HTR1BDRD3HTR1ADRD2
Hydrochloric Acid SCHEMBL2719588 0.87 HTR7 (1.00) HTR7HTR1BDRD3HTR1ADRD2
Hydrochloric Acid SCHEMBL2719586 0.87 HTR7 (1.00) HTR7HTR1BDRD3HTR1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2052251-A1 COMBINATION 5-HT7 RECEPTOR ANTAGONIST AND SEROTONIN REUPTAKE INHIBITOR THERAPY JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-29 — — EP claimed
WO-2008013556-A1 COMBINATION 5-HT7 RECEPTOR ANTAGONIST AND SEROTONIN REUPTAKE INHIBITOR THERAPY JANSSEN PHARMACEUTICAL N.V. (BE) 2008-01-31 — — WO claimed
EP-0912512-B1 SULPHONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 2003-04-02 — — EP claimed
US-6265408-B1 PSYCHOLOGICAL DISORDERS; ANTIDEPRESSANT SMITHKLINE BEECHAM PLC (GB) 2001-07-24 — — US claimed
EP-0912512-A1 SULPHONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 1999-05-06 — — EP claimed
WO-1997048681-A1 SULPHONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 1997-12-24 — — WO claimed
EP-2052251-A1 COMBINATION 5-HT7 RECEPTOR ANTAGONIST AND SEROTONIN REUPTAKE INHIBITOR THERAPY JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-29 — — EP disclosed
WO-2008013556-A1 COMBINATION 5-HT7 RECEPTOR ANTAGONIST AND SEROTONIN REUPTAKE INHIBITOR THERAPY JANSSEN PHARMACEUTICAL N.V. (BE) 2008-01-31 — — WO disclosed
WO-2006101828-A1 INSECTICIDAL ALKYLAMINO PHENYL SULFONAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2006-09-28 — — WO disclosed
EP-0912512-B1 SULPHONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 2003-04-02 — — EP disclosed
US-6265408-B1 PSYCHOLOGICAL DISORDERS; ANTIDEPRESSANT SMITHKLINE BEECHAM PLC (GB) 2001-07-24 — — US disclosed
EP-0912512-A1 SULPHONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 1999-05-06 — — EP disclosed
WO-1997048681-A1 SULPHONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 1997-12-24 — — WO disclosed
Send feedback